Fintel reports that on April 10, 2025, Stifel initiated coverage of Ligand Pharmaceuticals Incorporated - Equity Right (OTCPK ...

Fintel reports that on April 10, 2025, Stifel initiated coverage of Ligand Pharmaceuticals Incorporated - Equity Right (OTCPK ...

Stifel initiated coverage of Ligand (LGND) with a Buy rating and $143 price target Ligand, which provides “an important source of ...

Ligand earns Buy rating from Stifel for its royalty-based funding model and biotech partnerships amid strong revenue and earnings growth.

Cysteinyl leukotrienes (CysLTs) are potent bronchoconstrictors, playing pivotal roles in inflammatory diseases. These lipid ...

Chemists and chemical engineers at California Institute of Technology, working with a pair of colleagues from the University ...

Denosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the ...

A decade-long study finds that obesity is associated with a significantly increased risk for biologic treatment failure in ...

Rodolfo Hrosz has chosen to step down from his position as Managing Director of the company, effective April 30. He will be ...

See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of people with Parkinson’s (middle) and dementia with Lewy bodies (bottom), but ...